Delivery Order W81XWH12D0015-0005

This firm fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to the University of Massachusetts Medical School (UMass Medical) for the delivery of 15 adeno-associated virus (AAV) serotype 9 preps expressing human codon-optimized mMut and MMAB donor sequences. The $46,379 contract supports NCATS' Platform Vector Gene Therapy project and will be used to test gene therapy strategies in disease model...

This is a firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Allotropic TECH LLC, a for-profit limited liability company based in Halethorpe, Maryland. The $123,500 contract requires the contractor to train government personnel on the process of generating highly purified recombinant human acetylcholinesterase, which is suitable for use in research to measure the continued function of the protein. The contract has a performance period ending on December 11, 2024 and...

Battelle Memorial Institute, a large nonprofit research and development organization headquartered in Columbus, Ohio, was awarded a delivery order on September 30, 2024, by the National Institute on Drug Abuse for viral gene therapy development targeting Menkes disease. The contract, valued at $6.13M with a cost-plus-fixed-fee pricing structure, is scheduled for completion by September 29, 2027, and will be performed in Bethesda, Maryland. This delivery order falls under the larger...

This is a Cost No Fee federal contract award from the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to the University of Rochester for the development of transgenic and conventional knock-out mice. The $640,570.00 contract has an ultimate completion date of January 31, 2008 and was awarded on September 30, 2004. The contract does not have a set-aside designation. The University of Rochester is the prime contractor for this award, which supports specialized...

The National Center for Advancing Translational Sciences (NCATS) awarded a $366,923 cost-plus-fixed-fee delivery order to Lovelace Biomedical Research Institute on September 29, 2021, for efficacy and safety evaluation of a lead gene therapy candidate in methylmalonic acidemia (MMAB) disease mouse models and bioanalytical assay methods development. This delivery order is issued under a larger IDIQ contract valued at $48.8 million that Lovelace maintains with NCATS for pharmacology studies and...

This is a Cost Plus Fixed Fee contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Taconic Biosciences, Inc. (doing business as SAS Supply) for the production of B6C3F1 mice for studies conducted by the National Toxicology Program (NTP). The contract has a ceiling value of $2,987,126.32 and a period of performance through September 14, 2024. Taconic Biosciences, Inc. is a prime contractor that specializes in genetically engineered rodent...

This federal contract award from the Uniformed Services University of the Health Sciences, a defense agency, was issued to Taconic Biosciences, Inc., doing business as SAS Supply, for the delivery of a KO (knockout) repository model - TF-1380 mouse strain for research purposes. The firm fixed price purchase order has a ceiling value of $30,000.00 and an ultimate completion date of April 30, 2019. Taconic Biosciences is the prime contractor and did not utilize any subcontractors for this award....

This is a firm fixed-price contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Viralgen Vector Core SL, a for-profit organization located in Spain. The contract, valued at $533,124.00, is for the extension of stability testing up to 48 months and additional analytical testing to support the compatibility of the MMA-101 adeno-associated virus gene therapy candidate targeting methyl malonic acidemia. The contract is not set aside for any specific business...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Department of Health and Human Services (HHS) to Allele Biotechnology and Pharmaceuticals, Inc. for the development of novel protein expression technologies for glycosylated cancer-related proteins. The contract has a ceiling value of $150,000 and was awarded on September 30, 2009, with a completion date of March 30, 2010. Allele Biotechnology is a minority-owned, for-profit small business based in San...

The National Institute of Child Health and Human Development (NICHD) awarded a $21.5K time and materials BPA call contract to Taconic Biosciences, Inc. for the generation of a ROSA26 conditional targeted transgenesis vector (Quote #M-3421-AFLO-250714-A1). The contract was awarded on August 4, 2014, with an ultimate completion date of June 30, 2015, and will be performed in Bethesda, Maryland. No set-aside designation was applied to this award. Taconic Biosciences, a for-profit global leader in...